Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41,761 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Local mRNA Delivery from Nanocomposites Made of Gelatin and Hydroxyapatite Nanoparticles.
Andrée L, Egberink RO, Heesakkers R, Suurmond CE, Joziasse LS, Khalifeh M, Wang R, Yang F, Brock R, Leeuwenburgh SCG. Andrée L, et al. Among authors: wang r. ACS Appl Mater Interfaces. 2024 Sep 25;16(38):50497-50506. doi: 10.1021/acsami.4c12721. Epub 2024 Sep 16. ACS Appl Mater Interfaces. 2024. PMID: 39284017 Free PMC article.
Antibacterial Activity of Zinc-Doped Hydroxyapatite and Vancomycin-Loaded Gelatin Nanoparticles against Intracellular Staphylococcus aureus in Human THP-1 Derived Macrophages.
Cuypers LAB, de Boer L, Wang R, Walboomers XF, Yang F, Zaat SAJ, Leeuwenburgh SCG. Cuypers LAB, et al. Among authors: wang r. ACS Appl Nano Mater. 2024 Sep 11;7(18):21964-21974. doi: 10.1021/acsanm.4c03941. eCollection 2024 Sep 27. ACS Appl Nano Mater. 2024. PMID: 39360166 Free PMC article.
Spatial interactions of immune cells as potential predictors to efficacy of toripalimab plus chemotherapy in locally advanced or metastatic pancreatic ductal adenocarcinoma: a phase Ib/II trial.
Cheng K, Li X, Lv W, Zhao G, Zhou R, Chang C, Yang H, Li R, Li Z, Chen Y, Yi C, Yan O, Xiao C, Zhang Y, Xiong J, Huang Z, Shao W, You X, Guo W, He D, Ling W, Wang R, Tian B, Zhao C, Cao D. Cheng K, et al. Among authors: wang r. Signal Transduct Target Ther. 2024 Nov 25;9(1):321. doi: 10.1038/s41392-024-02031-8. Signal Transduct Target Ther. 2024. PMID: 39582060 Clinical Trial.
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial.
Yue D, Wang W, Liu H, Chen Q, Chen C, Liu L, Zhang P, Zhao G, Yang F, Han G, Cheng Y, Yu B, Yang Y, Chen H, Jiang J, Tan L, Xu S, Mao N, Hu J, Zhang L, Yao B, Wang S, Wang RH, Zheng W, Wang C; RATIONALE-315 investigators. Yue D, et al. Among authors: wang rh. Lancet Respir Med. 2024 Nov 21:S2213-2600(24)00269-8. doi: 10.1016/S2213-2600(24)00269-8. Online ahead of print. Lancet Respir Med. 2024. PMID: 39581197
41,761 results
You have reached the last available page of results. Please see the User Guide for more information.